Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Skin Anarchy

Kayleigh Christina & Danielle Gronich, Founders of Clearstem Skincare

03 Aug 2021

Description

Let’s ChatHolistic Nutritionist Kayleigh Christina is the co-founder of CLEARSTEM Skincare, a non-toxic skincare line that targets acne, anti-aging, and scar reversing utilizing premium ingredients. Christina’s journey into the skincare world started when she developed numerous health issues, including severe cystic acne in her mid-twenties and tried in vain to find a cure. Guided by a passion to make a positive impact, Christina studies the latest research on skin and whole-body wellness. She is the co-host of the Balancing Your Hustle podcast and published author of Healing with Apple Cider Vinegar: 115 Recipes for Health, Beauty, and Home.Danielle Gronich, known as The Acne Guru™, is the formulator and CEO of CLEARSTEM Skincare, a non-toxic skincare line that uses premium ingredients to correct acne, acne scars, DNA damage, and melasma. After her 10 year acne struggle and returning to school to earn her license, Gronich decided to open San Diego Acne Clinic in 2014. Her clinic takes a holistic approach with a 98% success rate for getting people clear and keeping them clear. Gronich is now known as the country's "Acne Guru". Today, her clinic has thousands of success stories to tell including celebrity clients.--- Send in a voice message: https://podcasters.spotify.com/pod/show/skincareanarchy/messageSupport this podcast: https://podcasters.spotify.com/pod/show/skincareanarchy/supportSupport the Show.Follow The Show On All Socials Using The Tag @skincareanarchy Hosted on Acast. See acast.com/privacy for more information.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.